-
41
Inosine enhances the efficacy of immune‐checkpoint inhibitors in advanced solid tumors: A randomized, controlled, Phase 2 study
Published 2024-09-01Subjects: Get full text
Article -
42
Extraction, GC-MS analysis, cytotoxic, anti-inflammatory and anticancer potential of Cannabis sativa female flower; in vitro, in vivo and in silico
Published 2025-02-01Subjects: Get full text
Article -
43
The Potential Role of sPD-L1 as a Predictive Biomarker in EGFR-Positive Non-Small-Cell Lung Cancer
Published 2025-01-01Subjects: Get full text
Article -
44
Efficacy and safety of PD-1/PD-L1 inhibitors in advanced or recurrent endometrial cancer: a meta-analysis with trial sequential analysis of randomized controlled trials
Published 2025-01-01Subjects: “…PD-1 inhibitors…”
Get full text
Article -
45
Efficacy and safety of immune checkpoint inhibitors in patients with advanced intrahepatic cholangiocarcinoma
Published 2025-02-01Subjects: Get full text
Article -
46
Periodontitis promotes tumor growth and immune evasion via PD-1/PD-L1
Published 2024-11-01Subjects: Get full text
Article -
47
A 10 GHz Dual-Loop PLL With Active Cycle-Jitter Correction Achieving 12dB Spur and 29% Jitter Reduction
Published 2024-01-01Subjects: “…Sampling-based PD (SPD)…”
Get full text
Article -
48
The Savvy Survey #8: Pilot Testing and Pretesting Questionnaires
Published 2015-02-01Subjects: Get full text
Article -
49
The Savvy Survey #6d: Constructing Indices for a Questionnaire
Published 2016-02-01Subjects: Get full text
Article -
50
Sampling the Evidence of Extension Program Impact
Published 2016-02-01Subjects: Get full text
Article -
51
The Savvy Survey #6d: Constructing Indices for a Questionnaire
Published 2016-02-01Subjects: Get full text
Article -
52
Sampling the Evidence of Extension Program Impact
Published 2016-02-01Subjects: Get full text
Article -
53
The Savvy Survey #8: Pilot Testing and Pretesting Questionnaires
Published 2015-02-01Subjects: Get full text
Article -
54
Prognostic significance of PD‐L2 expression in patients with oral squamous cell carcinoma—A comparison to the PD‐L1 expression profile
Published 2019-03-01Subjects: Get full text
Article -
55
Progression patterns in patients with advanced hepatocellular carcinoma treated with local therapy, targeted drugs, and PD-1/PD-L1 inhibitors
Published 2024-08-01Subjects: Get full text
Article -
56
Comparison of the Efficacy and Safety of PD‐1/PD‐L1 Inhibitors in the Treatment of Small Cell Lung Cancer
Published 2025-01-01Subjects: Get full text
Article -
57
Differences in immune-related toxicity between PD-1 and PD-L1 inhibitors: a retrospective cohort study in patients with advanced cancer
Published 2024-11-01Subjects: “…PD-1 inhibitors…”
Get full text
Article -
58
Lutetium-177 labeled iPD-L1 as a novel immunomodulator for cancer-targeted radiotherapy
Published 2025-01-01Subjects: “…PD-1…”
Get full text
Article -
59
-
60